{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["baicalein", "bioavailability", "cancer", "cell signaling pathways", "synergistic effects"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36432119", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "18"}], "Language": ["eng"], "ELocationID": ["8023", "10.3390/molecules27228023"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "22", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "18"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways.", "Abstract": {"AbstractText": ["The roles of medicinal plants or their purified bioactive compounds have attracted attention in the field of health sciences due to their low toxicity and minimal side effects. Baicalein is an active polyphenolic compound, isolated from <i>Scutellaria baicalensis,</i> and plays a significant role in the management of different diseases. Epidemiologic studies have proven that there is an inverse association between baicalein consumption and disease severity. Baicalein is known to display anticancer activity through the inhibition of inflammation and cell proliferation. Additionally, the anticancer potential of baicalein is chiefly mediated through the modulation of various cell-signaling pathways, such as the induction of apoptosis, autophagy, cell cycle arrest, inhibition of angiogenesis, signal transducer and activator of transcription 3, and PI3K/Akt pathways, as well as the regulation of other molecular targets. Therefore, the current review aimed to explore the role of baicalein in different types of cancer along with mechanisms of action. Besides this, the synergistic effects with other anti-cancerous drugs and the nano-formulation based delivery of baicalein have also been discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51542, Saudi Arabia."}], "LastName": "Rahmani", "ForeName": "Arshad Husain", "Initials": "AH"}, {"Identifier": ["0000-0002-1491-6402"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51542, Saudi Arabia."}], "LastName": "Almatroudi", "ForeName": "Ahmad", "Initials": "A"}, {"Identifier": ["0000-0001-6030-4493"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51542, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Amjad Ali", "Initials": "AA"}, {"Identifier": ["0000-0001-5960-3381"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51542, Saudi Arabia."}], "LastName": "Babiker", "ForeName": "Ali Yousif", "Initials": "AY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dentistry, Dr. Sulaiman Al Habib Medical Group, Qassim 51431, Saudi Arabia."}], "LastName": "Alanezi", "ForeName": "Malak", "Initials": "M"}, {"Identifier": ["0000-0002-6486-9835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51542, Saudi Arabia."}], "LastName": "Allemailem", "ForeName": "Khaled S", "Initials": "KS"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "49QAH60606", "NameOfSubstance": "baicalein"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavanones"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Scutellaria baicalensis"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Devi K.P., Rajavel T., Nabavi S.F., Setzer W.N., Ahmadi A., Mansouri K. Hesperidin: A promising anticancer agent from nature. Ind. Crops Prod. 2015;76:582\u2013589. doi: 10.1016/j.indcrop.2015.07.051.", "ArticleIdList": ["10.1016/j.indcrop.2015.07.051"]}, {"Citation": "Vineis P., Wild C.P. Global cancer patterns: Causes and prevention. Lancet. 2013;383:549\u2013557. doi: 10.1016/S0140-6736(13)62224-2.", "ArticleIdList": ["10.1016/S0140-6736(13)62224-2", "24351322"]}, {"Citation": "Wu S., Zhu W., Thompson P., Hannun Y.A. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat. Commun. 2018;9:3490. doi: 10.1038/s41467-018-05467-z.", "ArticleIdList": ["10.1038/s41467-018-05467-z", "PMC6113228", "30154431"]}, {"Citation": "Ames B.N. Mutagenesis and carcinogenesis: Endogenous and exogenous factors. Environ. Mol. Mutagen. 1989;14:66\u201377. doi: 10.1002/em.2850140614.", "ArticleIdList": ["10.1002/em.2850140614", "2659334"]}, {"Citation": "Hussain S.P., Harris C.C. Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogens. Mutat. Res. 2000;462:311\u2013322. doi: 10.1016/S1383-5742(00)00015-6.", "ArticleIdList": ["10.1016/S1383-5742(00)00015-6", "10767641"]}, {"Citation": "Almatroodi S., Alnuqaydan A., Alsahli M., Khan A., Rahmani A. Thymoquinone, the Most Prominent Constituent of Nigella Sativa, Attenuates Liver Damage in Streptozotocin-Induced Diabetic Rats via Regulation of Oxidative Stress, Inflammation and Cyclooxygenase-2 Protein Expression. Appl. Sci. 2021;11:3223. doi: 10.3390/app11073223.", "ArticleIdList": ["10.3390/app11073223"]}, {"Citation": "Alzohairy M.A., Khan A.A., Ansari M.A., Babiker A.Y., Alsahli M.A., Almatroodi S.A., Rahmani A.H. Protective Effect of Quercetin, a Flavonol against Benzo(a)pyrene-Induced Lung Injury via Inflammation, Oxidative Stress, Angiogenesis and Cyclooxygenase-2 Signalling Molecule. Appl. Sci. 2021;11:8675. doi: 10.3390/app11188675.", "ArticleIdList": ["10.3390/app11188675"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Alharbi H.M., Khan A.A., Rahmani A.H. Epigallocatechin-3-Gallate (EGCG), An Active Constituent of Green Tea: Implications in the Prevention of Liver Injury Induced by Diethylnitrosamine (DEN) in Rats. Appl. Sci. 2019;9:4821. doi: 10.3390/app9224821.", "ArticleIdList": ["10.3390/app9224821"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Rahmani A.H. Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways. Anti-Cancer Agents Med. Chem. 2019;19:1314\u20131324. doi: 10.2174/1871520619666190409100955.", "ArticleIdList": ["10.2174/1871520619666190409100955", "30963982"]}, {"Citation": "Syed M.A., Rahmani A.H. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer. Recent Patents Anti-Cancer Drug Discov. 2021;16:3\u201329. doi: 10.2174/1574892815999201102214602.", "ArticleIdList": ["10.2174/1574892815999201102214602", "33143616"]}, {"Citation": "Almatroudi A., Alsahli M.A., Alrumaihi F., Allemailem K.S., Rahmani A.H. Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways: A Review. Curr. Pharm. Biotechnol. 2019;20:5\u201316. doi: 10.2174/1389201020666190119142331.", "ArticleIdList": ["10.2174/1389201020666190119142331", "30659535"]}, {"Citation": "Thomasset S.C., Berry D.P., Garcea G., Marczylo T., Steward W.P., Gescher A.J. Dietary polyphenolic phytochemicals\u2014Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer. 2006;120:451\u2013458. doi: 10.1002/ijc.22419.", "ArticleIdList": ["10.1002/ijc.22419", "17131309"]}, {"Citation": "Bie B., Sun J., Guo Y., Li J., Jiang W., Yang J., Huang C., Li Z. Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomed. Pharmacother. 2017;93:1285\u20131291. doi: 10.1016/j.biopha.2017.07.068.", "ArticleIdList": ["10.1016/j.biopha.2017.07.068", "28747003"]}, {"Citation": "Dou J., Wang Z., Ma L., Peng B., Mao K., Li C., Su M., Zhou C., Peng G. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget. 2018;9:20089\u201320102. doi: 10.18632/oncotarget.24015.", "ArticleIdList": ["10.18632/oncotarget.24015", "PMC5929448", "29732005"]}, {"Citation": "Chen Z., Hou R., Gao S., Song D., Feng Y. Baicalein inhibits proliferation activity of human colorectal cancer cells HCT116 through downregulation of Ezrin. Cell Physiol. Biochem. 2018;49:2035\u20132046. doi: 10.1159/000493714.", "ArticleIdList": ["10.1159/000493714", "30244250"]}, {"Citation": "Rui X., Yan X.I., Zhang K. Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway. Oncol Lett. 2016;11:685\u2013688. doi: 10.3892/ol.2015.3935.", "ArticleIdList": ["10.3892/ol.2015.3935", "PMC4726933", "26870267"]}, {"Citation": "Yan W., Ma X., Zhao X., Zhang S. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des. Dev. Ther. 2018;12:3961\u20133972. doi: 10.2147/DDDT.S181939.", "ArticleIdList": ["10.2147/DDDT.S181939", "PMC6248272", "30510404"]}, {"Citation": "Kuo H.-M., Tsai H.-C., Lin Y.-L., Yang J.-S., Huang A.-C., Yang M.-D., Hsu S.-C., Chung M.-C., Wood W.G., Chung J.-G. Mitochondrial-Dependent Caspase Activation Pathway Is Involved in Baicalein-Induced Apoptosis in Human Hepatoma J5 Cells. Int. J. Oncol. 2009;35:717\u2013724.", "ArticleIdList": ["19724907"]}, {"Citation": "Zheng Y.-H., Yin L.-H., Grahn T.H.M., Ye A.-F., Zhao Y.-R., Zhang Q.-Y. Anticancer Effects of Baicalein on Hepatocellular Carcinoma Cells. Phytother. Res. 2014;28:1342\u20131348. doi: 10.1002/ptr.5135.", "ArticleIdList": ["10.1002/ptr.5135", "24596136"]}, {"Citation": "Siveen K.S., Sikka S., Surana R., Dai X., Zhang J., Kumar A.P., Tan B.K., Sethi G., Bishayee A. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim. Biophys. Acta Rev. Cancer. 2014;1845:136\u2013154. doi: 10.1016/j.bbcan.2013.12.005.", "ArticleIdList": ["10.1016/j.bbcan.2013.12.005", "24388873"]}, {"Citation": "Mantovani A. Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 2010;10:369\u2013373. doi: 10.2174/156652410791316968.", "ArticleIdList": ["10.2174/156652410791316968", "20455855"]}, {"Citation": "Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 2007;117:1175\u20131183. doi: 10.1172/JCI31537.", "ArticleIdList": ["10.1172/JCI31537", "PMC1857251", "17476347"]}, {"Citation": "Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells. Cell. 1998;93:705\u2013716. doi: 10.1016/S0092-8674(00)81433-6.", "ArticleIdList": ["10.1016/S0092-8674(00)81433-6", "9630216"]}, {"Citation": "Tsujii M., DuBois R.N. Alterations in cellular adhesions and apoptosis in epithelial cells overexpressing prostaglandin en-doperoxidase synthase. Cell. 1995;83:493\u2013501. doi: 10.1016/0092-8674(95)90127-2.", "ArticleIdList": ["10.1016/0092-8674(95)90127-2", "8521479"]}, {"Citation": "Ma G.-Z., Liu C.-H., Wei B., Qiao J., Lu T., Wei H.-C., Chen H.-D., He C.-D. Baicalein Inhibits DMBA/TPA-Induced Skin Tumorigenesis in Mice by Modulating Proliferation, Apoptosis, and Inflammation. Inflammation. 2012;36:457\u2013467. doi: 10.1007/s10753-012-9566-y.", "ArticleIdList": ["10.1007/s10753-012-9566-y", "23108957"]}, {"Citation": "Kim D.H., Hossain M.A., Kang Y.J., Jang J.Y., Lee Y.J., Im E., Yoon J.-H., Kim H.S., Chung H.Y., Kim N.D. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int. J. Oncol. 2013;43:1652\u20131658. doi: 10.3892/ijo.2013.2086.", "ArticleIdList": ["10.3892/ijo.2013.2086", "24008356"]}, {"Citation": "Chandrashekar N., Selvamani A., Subramanian R., Pandi A., Thiruvengadam D. Baicalein inhibits pulmonary carcinogene-sis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo. Toxicol. Appl. Pharmacol. 2012;261:10\u201321. doi: 10.1016/j.taap.2012.02.004.", "ArticleIdList": ["10.1016/j.taap.2012.02.004", "22369883"]}, {"Citation": "Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: Impli-cations for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 2001;17:615\u2013675. doi: 10.1146/annurev.cellbio.17.1.615.", "ArticleIdList": ["10.1146/annurev.cellbio.17.1.615", "11687500"]}, {"Citation": "Martini M., De Santis M.C., Braccini L., Gulluni F., Hirsch E. PI3K/AKT signaling pathway and cancer: An updated review. Ann. Med. 2014;46:372\u2013383. doi: 10.3109/07853890.2014.912836.", "ArticleIdList": ["10.3109/07853890.2014.912836", "24897931"]}, {"Citation": "Qiao D., Li Y., Xing J., Sun P., Wang Y., Zhang Y., Chen L., Ren X., Lin Z., Jin J., et al. Baicalein inhibits PI3K/AKT signaling pathway and induces autophagy of MGC-803 cells. Chin. J. Cell. Mol. Immunol. 2019;35:613\u2013618.", "ArticleIdList": ["31537246"]}, {"Citation": "Hassan M., Watari H., AbuAlmaaty A., Ohba Y., Sakuragi N. Apoptosis and molecular targeting therapy in cancer. BioMed Res. Int. 2014;2014:150845. doi: 10.1155/2014/150845.", "ArticleIdList": ["10.1155/2014/150845", "PMC4075070", "25013758"]}, {"Citation": "Mohammad R.M., Muqbil I., Lowe L., Yedjou C., Hsu H.-Y., Lin L.-T., Siegelin M.D., Fimognari C., Kumar N.B., Dou Q.P., et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 2015;35:S78\u2013S103. doi: 10.1016/j.semcancer.2015.03.001.", "ArticleIdList": ["10.1016/j.semcancer.2015.03.001", "PMC4720504", "25936818"]}, {"Citation": "Phan T., Nguyen V.H., Salazar M.A., Wong P., Diamond D.J., Yim J.H., Melstrom L.G. Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer. Mol. Ther. Oncolytics. 2020;19:1\u20137. doi: 10.1016/j.omto.2020.08.016.", "ArticleIdList": ["10.1016/j.omto.2020.08.016", "PMC7522588", "33024814"]}, {"Citation": "Sui X., Han X., Chen P., Wu Q., Feng J., Duan T., Chen X., Pan T., Yan L., Jin T., et al. Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling Pathway. Front. Mol. Biosci. 2021;7:602282. doi: 10.3389/fmolb.2020.602282.", "ArticleIdList": ["10.3389/fmolb.2020.602282", "PMC7876332", "33585556"]}, {"Citation": "Lin H., Hao Y., Wan X., He J., Tong Y. Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regu-lating ERK signaling pathway in osteosarcoma. J. Recept. Signal Transduct. Res. 2020;40:49\u201357. doi: 10.1080/10799893.2020.1713807.", "ArticleIdList": ["10.1080/10799893.2020.1713807", "31948366"]}, {"Citation": "Ye F., Wang H., Zhang L., Zou Y., Han H., Huang J. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression. Tumor Biol. 2015;36:4731\u20134740. doi: 10.1007/s13277-015-3122-y.", "ArticleIdList": ["10.1007/s13277-015-3122-y", "25618603"]}, {"Citation": "Elledge S.J. Cell Cycle Checkpoints: Preventing an Identity Crisis. Science. 1996;274:1664\u20131672. doi: 10.1126/science.274.5293.1664.", "ArticleIdList": ["10.1126/science.274.5293.1664", "8939848"]}, {"Citation": "Bartek J., Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 2001;13:738\u2013747. doi: 10.1016/S0955-0674(00)00280-5.", "ArticleIdList": ["10.1016/S0955-0674(00)00280-5", "11698191"]}, {"Citation": "Wang Y., Ji P., Liu J., Broaddus R.R., Xue F., Zhang W. Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy. Mol. Cancer. 2009;8:8. doi: 10.1186/1476-4598-8-8.", "ArticleIdList": ["10.1186/1476-4598-8-8", "PMC2657106", "19216791"]}, {"Citation": "L\u00f6brich M., Jeggo P.A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat. Rev. Cancer. 2007;7:861\u2013869. doi: 10.1038/nrc2248.", "ArticleIdList": ["10.1038/nrc2248", "17943134"]}, {"Citation": "Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316\u2013323. doi: 10.1038/nature03097.", "ArticleIdList": ["10.1038/nature03097", "15549093"]}, {"Citation": "Zhang Y., Song L., Cai L., Wei R., Hu H., Jin W. Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells. Food Chem. Toxicol. 2013;53:325\u2013333. doi: 10.1016/j.fct.2012.12.019.", "ArticleIdList": ["10.1016/j.fct.2012.12.019", "23266503"]}, {"Citation": "Lee H.Z., Leung H.W.C., Lai M.Y., Wu C.H. Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res. 2005;25:959\u2013964.", "ArticleIdList": ["15868934"]}, {"Citation": "Hu J., Wang R., Liu Y., Zhou J., Shen K., Dai Y. Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis. Oncol. Targets Ther. 2021;9:905\u2013916. doi: 10.2147/OTT.S282790.", "ArticleIdList": ["10.2147/OTT.S282790", "PMC7881781", "33603395"]}, {"Citation": "Holmgren L., O\u2019Reilly M.S., Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1995;1:149\u2013153. doi: 10.1038/nm0295-149.", "ArticleIdList": ["10.1038/nm0295-149", "7585012"]}, {"Citation": "Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer. 1996;32A:2413\u20132422. doi: 10.1016/S0959-8049(96)00387-5.", "ArticleIdList": ["10.1016/S0959-8049(96)00387-5", "9059329"]}, {"Citation": "Rahmani A.H., Ababiker A.Y., Alsahli M.A., Almatroodi S.A., Husain N.E.O.S. Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma. Open Access Maced. J. Med. Sci. 2018;6:263\u2013268. doi: 10.3889/oamjms.2018.089.", "ArticleIdList": ["10.3889/oamjms.2018.089", "PMC5839429", "29531585"]}, {"Citation": "Babiker A.Y., Almatroodi S.A., Almatroudi A., Alrumaihi F., Abdalaziz M.S., Alsahli M.A., Rahmani A.H. Clinicopathological significance of VEGF and pAkt expressions in oral squamous cell car-cinoma. All Life. 2020;13:507\u2013515. doi: 10.1080/26895293.2020.1815595.", "ArticleIdList": ["10.1080/26895293.2020.1815595"]}, {"Citation": "Chen J., Li Z., Chen A.Y., Ye X., Luo H., Rankin G.O., Chen Y.C. Inhibitory Effect of Baicalin and Baicalein on Ovarian Cancer Cells. Int. J. Mol. Sci. 2013;14:6012\u20136025. doi: 10.3390/ijms14036012.", "ArticleIdList": ["10.3390/ijms14036012", "PMC3634505", "23502466"]}, {"Citation": "Park Y.-G., Choi J., Jung H.-K., Kim B., Kim C., Park S.-Y., Seol J.-W. Baicalein inhibits tumor progression by inhibiting tumor cell growth and tumor angiogenesis. Oncol. Rep. 2017;38:3011\u20133018. doi: 10.3892/or.2017.6007.", "ArticleIdList": ["10.3892/or.2017.6007", "29048641"]}, {"Citation": "Cathcart M.-C., Useckaite Z., Drakeford C., Semik V., Lysaght J., Gately K., O\u2019Byrne K.J., Pidgeon G.P. Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo. BMC Cancer. 2016;16:707. doi: 10.1186/s12885-016-2740-0.", "ArticleIdList": ["10.1186/s12885-016-2740-0", "PMC5009689", "27586635"]}, {"Citation": "Lim K.H., Staudt L.M. Toll-like receptor signaling. Cold Spring Harbor Perspect. Biol. 2013;5:a011247. doi: 10.1101/cshperspect.a011247.", "ArticleIdList": ["10.1101/cshperspect.a011247", "PMC3579400", "23284045"]}, {"Citation": "Salminen A., Kaarniranta K., Kauppinen A. Beclin 1 interactome controls the crosstalk between apoptosis, autophagy and inflammasome activation: Impact on the aging process. Ageing Res. Rev. 2013;12:520\u2013534. doi: 10.1016/j.arr.2012.11.004.", "ArticleIdList": ["10.1016/j.arr.2012.11.004", "23220384"]}, {"Citation": "Panda P.K., Mukhopadhyay S., Das D.N., Sinha N., Naik P.P., Bhutia S.K. Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics. Semin. Cell Dev. Biol. 2015;39:43\u201355. doi: 10.1016/j.semcdb.2015.02.013.", "ArticleIdList": ["10.1016/j.semcdb.2015.02.013", "25724561"]}, {"Citation": "Aryal P., Kim K., Park P.-H., Ham S., Cho J., Song K. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells. FEBS J. 2014;281:4644\u20134658. doi: 10.1111/febs.12969.", "ArticleIdList": ["10.1111/febs.12969", "25132405"]}, {"Citation": "Li P., Hu J., Shi B., Tie J. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. Biochem. Biophys. Res. Commun. 2020;531:320\u2013327. doi: 10.1016/j.bbrc.2020.07.045.", "ArticleIdList": ["10.1016/j.bbrc.2020.07.045", "32800561"]}, {"Citation": "Yi S., Liu G., Wu Y., Liang Q., Li L. Baicalein suppresses the growth of the human thyroid cancer cells by inducing mitotic ca-tastrophe, apoptosis and autophagy via NF-kB signalling pathway. J. BUON. 2020;25:389\u2013394.", "ArticleIdList": ["32277659"]}, {"Citation": "Wang M., Qiu S., Qin J. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway. Am. J. Transl. Res. 2019;11:3341\u20133352.", "ArticleIdList": ["PMC6614652", "31312348"]}, {"Citation": "Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E., Jr. Stat3 as an oncogene. Cell. 1999;98:295\u2013303. doi: 10.1016/S0092-8674(00)81959-5.", "ArticleIdList": ["10.1016/S0092-8674(00)81959-5", "10458605"]}, {"Citation": "Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mul\u00e9 J., Kerr W.G., et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent an-titumor immunity. Nat. Med. 2005;11:1314\u20131321. doi: 10.1038/nm1325.", "ArticleIdList": ["10.1038/nm1325", "16288283"]}, {"Citation": "Dong S., Chen S.J., Tweardy D.J. Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leu-kemia. Leuk. Lymphoma. 2003;44:2023\u20132029. doi: 10.1080/1042819031000116670.", "ArticleIdList": ["10.1080/1042819031000116670", "14959844"]}, {"Citation": "Susmitha G.D., Miyazato K., Ogura K., Yokoyama S., Hayakawa Y. Anti-metastatic Effects of Baicalein by Targeting STAT3 Activity in Breast Cancer Cells. Biol. Pharm. Bull. 2020;43:1899\u20131905. doi: 10.1248/bpb.b20-00571.", "ArticleIdList": ["10.1248/bpb.b20-00571", "33268707"]}, {"Citation": "Lei H., Shi J., Teng Y., Song C., Zou L., Ye F., Zhang H. Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway. Adv. Clin. Exp. Med. 2021;30:727\u2013736. doi: 10.17219/acem/135478.", "ArticleIdList": ["10.17219/acem/135478", "34118143"]}, {"Citation": "Yaylag\u00fcl E., \u00dclger C. The effect of baicalein on Wnt/\u03b2-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line. Turk. J. Med. Sci. 2020;50:1168\u20131179. doi: 10.3906/sag-2001-161.", "ArticleIdList": ["10.3906/sag-2001-161", "PMC7379426", "32283909"]}, {"Citation": "Zhang F.W., Peng L.Y., Shi C.J., Li J.C., Pang F.X., Fu W.M., Fu W., Pan X., Zhang J. Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/\u03b2-catenin signaling regulatory axis. J. Orthop. Transl. 2022;33:132\u2013141. doi: 10.1016/j.jot.2021.12.001.", "ArticleIdList": ["10.1016/j.jot.2021.12.001", "PMC8919235", "35330943"]}, {"Citation": "Rahmani A., Alzohairy M., Babiker A.Y., Rizvi M.A., Elkarimahmad H.G. Clinicopathological significance of PTEN and bcl2 ex-pressions in oral squamous cell carcinoma. Int. J. Clin. Exp. Pathol. 2012;5:965\u2013971.", "ArticleIdList": ["PMC3484492", "23119114"]}, {"Citation": "Babiker A.Y., Almatroudi A., Allemailem K.S., Husain N.E.O.S., Alsammani M.A., Alsahli M.A., Rahmani A.H. Clinicopathologic Aspects of Squamous Cell Carcinoma of the Uterine Cervix: Role of PTEN, BCL2 and P53. Appl. Sci. 2018;8:2124. doi: 10.3390/app8112124.", "ArticleIdList": ["10.3390/app8112124"]}, {"Citation": "Pulido R., Baker S.J., Barata J.T., Carracedo A., Cid V.J., Chin-Sang I.D., Dav\u00e9 V., Hertog J.D., Devreotes P., Eickholt B.J., et al. A Unified Nomenclature and Amino Acid Numbering for Human PTEN. Sci. Signal. 2014;7:pe15. doi: 10.1126/scisignal.2005560.", "ArticleIdList": ["10.1126/scisignal.2005560", "PMC4367864", "24985344"]}, {"Citation": "Chen F., Zhuang M., Zhong C., Peng J., Wang X., Li J., Chen Z., Huang Y. Baicalein reverses hypoxia-induced 5-FU re-sistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1\u03b1 signaling pathway. Oncol. Rep. 2015;33:457\u2013463. doi: 10.3892/or.2014.3550.", "ArticleIdList": ["10.3892/or.2014.3550", "25333894"]}, {"Citation": "Lu C., Wang H., Chen S., Yang R., Li H., Zhang G. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway. J. Cell Mol. Med. 2018;22:2478\u20132487. doi: 10.1111/jcmm.13556.", "ArticleIdList": ["10.1111/jcmm.13556", "PMC5867147", "29392841"]}, {"Citation": "Plotnikov A., Flores K., Maik-Rachline G., Zehorai E., Kapri-Pardes E., Berti D.A., Hanoch T., Besser M.J., Seger R. The nuclear translocation of ERK1/2 as an anticancer target. Nat. Commun. 2015;6:6685. doi: 10.1038/ncomms7685.", "ArticleIdList": ["10.1038/ncomms7685", "25819065"]}, {"Citation": "Koul H.K., Pal M., Koul S. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer. 2013;4:342\u2013359. doi: 10.1177/1947601913507951.", "ArticleIdList": ["10.1177/1947601913507951", "PMC3863344", "24349632"]}, {"Citation": "Burotto M., Chiou V.L., Lee J.-M., Kohn E.C. The MAPK pathway across different malignancies: A new perspective. Cancer. 2014;120:3446\u20133456. doi: 10.1002/cncr.28864.", "ArticleIdList": ["10.1002/cncr.28864", "PMC4221543", "24948110"]}, {"Citation": "Zhang W., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9\u201318. doi: 10.1038/sj.cr.7290105.", "ArticleIdList": ["10.1038/sj.cr.7290105", "11942415"]}, {"Citation": "Kyriakis J.M., Avruch J. Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update. Physiol. Rev. 2012;92:689\u2013737. doi: 10.1152/physrev.00028.2011.", "ArticleIdList": ["10.1152/physrev.00028.2011", "22535895"]}, {"Citation": "Dong C., Davis R.J., Flavell R.A. MAP Kinases in the Immune Response. Annu. Rev. Immunol. 2002;20:55\u201372. doi: 10.1146/annurev.immunol.20.091301.131133.", "ArticleIdList": ["10.1146/annurev.immunol.20.091301.131133", "11861597"]}, {"Citation": "Zhou Q.-M., Wang S., Zhang H., Lu Y.-Y., Wang X.-F., Motoo Y., Su S.-B. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol. Sin. 2009;30:1648\u20131658. doi: 10.1038/aps.2009.166.", "ArticleIdList": ["10.1038/aps.2009.166", "PMC4007493", "19960010"]}, {"Citation": "Chen K., Zhang S., Ji Y., Li J., An P., Ren H., Liang R., Yang J., Li Z. Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepato-cellular Carcinoma Cells via Down-Regulation of the ERK Pathway. PLoS ONE. 2013;8:e72927.", "ArticleIdList": ["PMC3765161", "24039823"]}, {"Citation": "Fitzmaurice C., Allen C., Barber R.M., Barregard L., Bhutta Z.A., Brenner H., Dicker D.J., Chimed-Orchir O., Dandona R., Dandona L., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524.", "ArticleIdList": ["PMC6103527", "27918777"]}, {"Citation": "Leslie S.W., Soon-Sutton T.L., Sajjad H., Siref L.E. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2020. Prostate Cancer.", "ArticleIdList": ["29261872"]}, {"Citation": "Guo Z., Hu X., Xing Z., Xing R., Lv R., Cheng X., Su J., Zhou Z., Xu Z., Nilsson S., et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Mol. Cell Biochem. 2015;406:111\u2013119. doi: 10.1007/s11010-015-2429-8.", "ArticleIdList": ["10.1007/s11010-015-2429-8", "PMC4502300", "25957503"]}, {"Citation": "Miocinovic R., McCabe N., Keck R., Jankun J., Hampton J., Selman S. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int. J. Oncol. 2005;26:241\u2013246. doi: 10.3892/ijo.26.1.241.", "ArticleIdList": ["10.3892/ijo.26.1.241", "15586246"]}, {"Citation": "Bie B., Sun J., Li J., Guo Y., Jiang W., Huang C., Yang J., Li Z. Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells. Cell Physiol. Biochem. 2017;41:1519\u20131531. doi: 10.1159/000470815.", "ArticleIdList": ["10.1159/000470815", "28351032"]}, {"Citation": "Chen C.-H., Huang L.L.H., Huang C.-C., Lin C.-C., Lee Y., Lu F.-J. Baicalein, a Novel Apoptotic Agent for Hepatoma Cell Lines:A Potential Medicine for Hepatoma. Nutr. Cancer. 2000;38:287\u2013295. doi: 10.1207/S15327914NC382_19.", "ArticleIdList": ["10.1207/S15327914NC382_19", "11525608"]}, {"Citation": "Liang R.R., Zhang S., Qi J.A., Wang Z.D., Li J., Liu P.J., Huang C., Le X.F., Yang J., Li Z.F. Preferential inhibition of hepatocellular car-cinoma by the flavonoid Baicalein through blocking MEK-ERK signaling. Int. J. Oncol. 2012;41:969\u2013978. doi: 10.3892/ijo.2012.1510.", "ArticleIdList": ["10.3892/ijo.2012.1510", "22684543"]}, {"Citation": "Yu X., Tang W., Yang Y., Tang L., Dai R., Pu B., Feng C., Xia J. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-\u03baB signaling. Chem. Biol. Interact. 2018;285:48\u201358. doi: 10.1016/j.cbi.2018.02.027.", "ArticleIdList": ["10.1016/j.cbi.2018.02.027", "29481769"]}, {"Citation": "Li J., Duan B., Guo Y., Zhou R., Sun J., Bie B., Yang S., Huang C., Yang J., Li Z. Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity. Biomed. Pharmacother. 2018;98:806\u2013812. doi: 10.1016/j.biopha.2018.01.002.", "ArticleIdList": ["10.1016/j.biopha.2018.01.002", "29571250"]}, {"Citation": "Zhang Y., Chen Z., Li X., He J., Liu Z., Yang L. Baicalein flavone targets cisplatin resistant human pancreatic cancer cells via inducing S-phase cell cycle arrest, inhibition of cell migration and invasion, caspase activation and mitochondrial-dependent apoptosis. J. BUON. 2020;25:1947\u20131953.", "ArticleIdList": ["33099937"]}, {"Citation": "Liu P., Feng J., Sun M., Yuan W., Xiao R., Xiong J., Huang X., Xiong M., Chen W., Yu X., et al. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells. Int. J. Oncol. 2017;51:1878\u20131886. doi: 10.3892/ijo.2017.4153.", "ArticleIdList": ["10.3892/ijo.2017.4153", "29039524"]}, {"Citation": "Takahashi H., Chen M.C., Pham H., Angst E., King J.C., Park J., Brovman E.Y., Ishiguro H., Harris D.M., Reber H.A., et al. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim. Biophys. Acta. 2011;1813:1465\u20131474. doi: 10.1016/j.bbamcr.2011.05.003.", "ArticleIdList": ["10.1016/j.bbamcr.2011.05.003", "PMC3123440", "21596068"]}, {"Citation": "Chen F., Zhuang M., Peng J., Wang X., Huang T., Li S., Lin M., Lin H., Xu Y., Li J., et al. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-\u03b2 signaling pathway. Mol. Med. Rep. 2014;10:1999\u20132003. doi: 10.3892/mmr.2014.2452.", "ArticleIdList": ["10.3892/mmr.2014.2452", "25109410"]}, {"Citation": "Mu J., Liu T., Jiang L., Wu X., Cao Y., Li M., Dong Q., Liu Y., Xu H. The Traditional Chinese Medicine Baicalein Potently Inhibits Gastric Cancer Cells. J. Cancer. 2016;7:453\u2013461. doi: 10.7150/jca.13548.", "ArticleIdList": ["10.7150/jca.13548", "PMC4749366", "26918059"]}, {"Citation": "Liu T.-Y., Gong W., Tan Z.-J., Lu W., Wu X.-S., Weng H., Ding Q., Shu Y.-J., Bao R.-F., Cao Y., et al. Baicalein Inhibits Progression of Gallbladder Cancer Cells by Downregulating ZFX. PLoS ONE. 2015;10:e0114851. doi: 10.1371/journal.pone.0114851.", "ArticleIdList": ["10.1371/journal.pone.0114851", "PMC4305301", "25617627"]}, {"Citation": "Li H.-L., Zhang S., Wang Y., Liang R.-R., Li J., An P., Wang Z.-M., Yang J., Li Z.-F. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells. Mol. Med. Rep. 2013;7:266\u2013270. doi: 10.3892/mmr.2012.1123.", "ArticleIdList": ["10.3892/mmr.2012.1123", "23064738"]}, {"Citation": "Wu J.Y., Tsai K.W., Li Y.Z., Chang Y.S., Lai Y.C., Laio Y.H., Wu J.D., Liu Y.W. Anti-Bladder-Tumor Effect of Baicalein from Scutellaria baicalensis Georgi and Its Application In Vivo. Evid. Based Complement Alternat. Med. 2013;2013:579751.", "ArticleIdList": ["PMC3613056", "23573134"]}, {"Citation": "Choi E.-O., Park C., Hwang H.-J., Hong S.H., Kim G.-Y., Cho E.-J., Kim W.-J., Choi Y.H. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells. Int. J. Oncol. 2016;49:1009\u20131018. doi: 10.3892/ijo.2016.3606.", "ArticleIdList": ["10.3892/ijo.2016.3606", "27571890"]}, {"Citation": "Han P., Shang J., Chen D.L., Li S.Y., Fan R., Li R.H., Li H.Q., Zhang S.Y., Shen D.Y. Baicalein mediates anticancer effect on cholan-giocarcinoma through co-targeting the AKT/NF-\u03baB and STAT3 signaling pathway. Process Biochem. 2021;102:304\u2013314. doi: 10.1016/j.procbio.2021.01.017.", "ArticleIdList": ["10.1016/j.procbio.2021.01.017"]}, {"Citation": "Kim S.-J., Kim H.-J., Kim H.-R., Lee S.-H., Cho S.-D., Choi C.-S., Nam J.-S., Jung J.-Y. Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells. Mol. Med. Rep. 2012;6:1443\u20131449. doi: 10.3892/mmr.2012.1085.", "ArticleIdList": ["10.3892/mmr.2012.1085", "22992837"]}, {"Citation": "Gao X.-Y., Xue X.-H., Ma Y.-N., Zhang S.-Q. Effect of baicalein on the expression of SATB1 in human breast cancer cells. Exp. Ther. Med. 2015;9:1665\u20131669. doi: 10.3892/etm.2015.2329.", "ArticleIdList": ["10.3892/etm.2015.2329", "PMC4471683", "26136875"]}, {"Citation": "Po L.S., Chen Z.Y., Tsang D.S., Leung L.K. Baicalein and genistein display differential actions on estrogen receptor (ER) transac-tivation and apoptosis in MCF-7 cells. Cancer Lett. 2002;187:33\u201340. doi: 10.1016/S0304-3835(02)00355-5.", "ArticleIdList": ["10.1016/S0304-3835(02)00355-5", "12359348"]}, {"Citation": "Zhao X., Qu J., Liu X., Wang J., Ma X., Zhao X., Yang Q., Yan W., Zhao Z., Hui Y., et al. Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization. Am. J. Cancer Res. 2018;8:1528\u20131540.", "ArticleIdList": ["PMC6129485", "30210921"]}, {"Citation": "Wu X., Yang Z., Dang H., Peng H., Dai Z. Baicalein Inhibits the Proliferation of Cervical Cancer Cells Through the GSK3\u03b2-Dependent Pathway. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 2018;26:645\u2013653. doi: 10.3727/096504017X15031557924141.", "ArticleIdList": ["10.3727/096504017X15031557924141", "PMC7844692", "28835320"]}, {"Citation": "Yu X., Yang Y., Li Y., Cao Y., Tang L., Chen F., Xia J. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3 K/Akt pathway. Int. J. Biochem. Cell Biol. 2017;94:107\u2013118. doi: 10.1016/j.biocel.2017.11.009.", "ArticleIdList": ["10.1016/j.biocel.2017.11.009", "29175387"]}, {"Citation": "Wang Q., Xu H., Zhao X. Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway. Med. Sci. Monit. 2018;24:1955\u20131961. doi: 10.12659/MSM.909640.", "ArticleIdList": ["10.12659/MSM.909640", "PMC5896362", "29610452"]}, {"Citation": "Yan H., Xin S., Wang H., Ma J., Zhang H., Wei H. Baicalein inhibits MMP-2 expression in human ovarian cancer cells by sup-pressing the p38 MAPK-dependent NF-\u03baB signaling pathway. Anticancer Drugs. 2015;26:649\u2013656. doi: 10.1097/CAD.0000000000000230.", "ArticleIdList": ["10.1097/CAD.0000000000000230", "25811965"]}, {"Citation": "Zhang H.-B., Lu P., Guo Q.-Y., Zhang Z.-H., Meng X.-Y. Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway. Oncol. Lett. 2012;5:722\u2013728. doi: 10.3892/ol.2012.1069.", "ArticleIdList": ["10.3892/ol.2012.1069", "PMC3572959", "23420294"]}, {"Citation": "Deng X., Liu J., Liu L., Sun X., Huang J., Dong J. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway. Int. J. Biol. Sci. 2020;16:1403\u20131416. doi: 10.7150/ijbs.41768.", "ArticleIdList": ["10.7150/ijbs.41768", "PMC7085231", "32210728"]}, {"Citation": "Zhang J., Yang W., Zhou Y., Xiang Y., Wang L., Hu W., Wang W. Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR 183/Ezrin pathway. Mol. Med. Rep. 2018;18:1104\u20131112. doi: 10.3892/mmr.2018.9036.", "ArticleIdList": ["10.3892/mmr.2018.9036", "29845278"]}, {"Citation": "Dai G., Zheng D., Wang Q., Yang J., Liu G., Song Q., Sun X., Tao C., Hu Q., Gao T., et al. Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/\u03b2-catenin signaling pathway. Oncotarget. 2017;8:86098\u201386116. doi: 10.18632/oncotarget.20987.", "ArticleIdList": ["10.18632/oncotarget.20987", "PMC5689670", "29156780"]}, {"Citation": "Li B., Lu M., Jiang X.X., Pan M.X., Mao J.W., Chen M. Inhibiting reactive oxygen species-dependent autophagy enhanced bai-calein-induced apoptosis in oral squamous cell carcinoma. J. Nat. Med. 2017;71:433\u2013441. doi: 10.1007/s11418-017-1076-7.", "ArticleIdList": ["10.1007/s11418-017-1076-7", "28176233"]}, {"Citation": "Gao Z., Zhang Y., Zhou H., Lv J. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor SpInt. J. Oncol. 2019;56:273\u2013282. doi: 10.3892/ijo.2019.4894.", "ArticleIdList": ["10.3892/ijo.2019.4894", "31746368"]}, {"Citation": "Cheng Y.-H., Li L.-A., Lin P., Cheng L.-C., Hung C.-H., Chang N.W., Lin C. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol. Appl. Pharmacol. 2012;263:360\u2013367. doi: 10.1016/j.taap.2012.07.010.", "ArticleIdList": ["10.1016/j.taap.2012.07.010", "22820424"]}, {"Citation": "Park C.H., Han S.E., Nam-Goong I.S., Kim Y.I., Kim E.S. Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c An-aplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways. Endocrinol. Metab. 2018;33:121\u2013132. doi: 10.3803/EnM.2018.33.1.121.", "ArticleIdList": ["10.3803/EnM.2018.33.1.121", "PMC5874188", "29589394"]}, {"Citation": "Jiang G., Zhang L., Wang J., Zhou H. Baicalein Induces the Apoptosis of U251 Glioblastoma Cell Lines via the NF-kB-P65-Mediated Mechanism. Anim. Cell Syst. 2016;20:296\u2013302. doi: 10.1080/19768354.2016.1229216.", "ArticleIdList": ["10.1080/19768354.2016.1229216"]}, {"Citation": "Huang L., Peng B., Nayak Y., Wang C., Si F., Liu X., Dou J., Xu H., Peng G. Baicalein and Baicalin Promote Melanoma Apoptosis and Senescence via Metabolic Inhibition. Front. Cell Dev. Biol. 2020;8:836. doi: 10.3389/fcell.2020.00836.", "ArticleIdList": ["10.3389/fcell.2020.00836", "PMC7477299", "32984331"]}, {"Citation": "Choi E.-O., Cho E.-J., Jeong J.-W., Park C., Hong S.-H., Hwang H.-J., Moon S.-K., Son C.G., Kim W.-J., Choi Y.H. Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway. Biomol. Ther. 2017;25:213\u2013221. doi: 10.4062/biomolther.2016.094.", "ArticleIdList": ["10.4062/biomolther.2016.094", "PMC5340547", "27530117"]}, {"Citation": "Yu C., Zeng J., Yan Z., Ma Z., Liu S., Huang Z. Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest. Cell Biosci. 2016;6:20. doi: 10.1186/s13578-016-0084-8.", "ArticleIdList": ["10.1186/s13578-016-0084-8", "PMC4818455", "27042290"]}, {"Citation": "Li Y., Tyan Y., Kuo H., Chang W., Hsia T., Chung J. Baicalein induced in vitro apoptosis undergo caspases activity in human promyelocytic leukemia HL-60 cells. Food Chem. Toxicol. 2003;42:37\u201343. doi: 10.1016/j.fct.2003.08.014.", "ArticleIdList": ["10.1016/j.fct.2003.08.014", "14630128"]}, {"Citation": "Liu S., Ma Z., Cai H., Li Q., Rong W., Kawano M. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur. J. Haematol. 2010;84:137\u2013144. doi: 10.1111/j.1600-0609.2009.01365.x.", "ArticleIdList": ["10.1111/j.1600-0609.2009.01365.x", "19878271"]}, {"Citation": "Patwardhan R.S., Pal D., Checker R., Sharma D., Sandur S.K. Baicalein induces cell death in murine T cell lymphoma via inhibition of thioredoxin system. Int. J. Biochem. Cell Biol. 2017;91:45\u201352. doi: 10.1016/j.biocel.2017.08.015.", "ArticleIdList": ["10.1016/j.biocel.2017.08.015", "28864268"]}, {"Citation": "Su M.-Q., Zhou Y.-R., Rao X., Yang H., Zhuang X.H., Ke X.-J., Peng G.-Y., Zhou C.-L., Shen B.-Y., Dou J. Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs. Int. J. Oncol. 2018;53:750\u2013760.", "ArticleIdList": ["29749481"]}, {"Citation": "Yersal O., Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J. Clin. Oncol. 2014;5:412. doi: 10.5306/wjco.v5.i3.412.", "ArticleIdList": ["10.5306/wjco.v5.i3.412", "PMC4127612", "25114856"]}, {"Citation": "Baliu-Piqu\u00e9 M., Pandiella A., Ocana A. Breast Cancer Heterogeneity and Response to Novel Therapeutics. Cancers. 2020;12:3271. doi: 10.3390/cancers12113271.", "ArticleIdList": ["10.3390/cancers12113271", "PMC7694303", "33167363"]}, {"Citation": "Yu X., Xia J., Cao Y., Tang L., Tang X., Li Z. SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regu-lating miR-3127-5p/FZD4/Wnt/\u03b2-catenin signaling. Exp. Biol. Med. 2021;246:20\u201330. doi: 10.1177/1535370220955139.", "ArticleIdList": ["10.1177/1535370220955139", "PMC7798002", "32883110"]}, {"Citation": "Wang Y.-F., Xu Y.-L., Tang Z.-H., Li T., Zhang L.-L., Chen X., Lu J., Leung C.-H., Ma D.-L., Qiang W.-A., et al. Baicalein Induces Beclin 1- and Extracellular Signal-Regulated Kinase-Dependent Autophagy in Ovarian Cancer Cells. Am. J. Chin. Med. 2017;45:123\u2013136. doi: 10.1142/S0192415X17500094.", "ArticleIdList": ["10.1142/S0192415X17500094", "28081631"]}, {"Citation": "Wang F.-R., Jiang Y.-S. Effect of treatment with baicalein on the intracerebral tumor growth and survival of orthotopic glioma models. J. Neuro-Oncol. 2015;124:5\u201311. doi: 10.1007/s11060-015-1804-3.", "ArticleIdList": ["10.1007/s11060-015-1804-3", "25968345"]}, {"Citation": "Chen Y.J., Wu C.S., Shieh J.J., Wu J.H., Chen H.Y., Chung T.W., Chen Y.K., Lin C.C. Baicalein Triggers Mitochondria-Mediated Apoptosis and Enhances the Antileukemic Effect of Vincristine in Childhood Acute Lymphoblastic Leukemia CCRF-CEM Cells. Evid. Based Complement. Alternat. Med. 2013;2013:124747. doi: 10.1155/2013/124747.", "ArticleIdList": ["10.1155/2013/124747", "PMC3580913", "23476680"]}, {"Citation": "Liu X.-P., He L., Zhang Q.-P., Zeng X.-T., Liu S.-Q. Baicalein Inhibits Proliferation of Myeloma U266 Cells by Downregulating IKZF1 and IKZF. Med. Sci. Monit. 2018;24:2809\u20132817. doi: 10.12659/MSM.907058.", "ArticleIdList": ["10.12659/MSM.907058", "PMC5958785", "29729093"]}, {"Citation": "Gu Y.-Y., Liu L.-P., Qin J., Zhang M., Chen Y., Wang D., Li Z., Tang J.-Z., Mo S.-L. Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro. Fitoterapia. 2014;94:21\u201328. doi: 10.1016/j.fitote.2014.01.019.", "ArticleIdList": ["10.1016/j.fitote.2014.01.019", "24468191"]}, {"Citation": "Tian S., He G., Song J., Wang S., Xin W., Zhang D., Du G. Pharmacokinetic study of baicalein after oral administration in monkeys. Fitoterapia. 2012;83:532\u2013540. doi: 10.1016/j.fitote.2011.12.019.", "ArticleIdList": ["10.1016/j.fitote.2011.12.019", "22245084"]}, {"Citation": "Li M., Shi A., Pang H., Xue W., Li Y., Cao G., Yan B., Dong F., Li K., Xiao W., et al. Safety, tolerability, and pharma-cokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J. Ethnopharmacol. 2014;28:210\u2013215. doi: 10.1016/j.jep.2014.08.031.", "ArticleIdList": ["10.1016/j.jep.2014.08.031", "25219601"]}, {"Citation": "Li W., Pi J., Zhang Y., Ma X., Wang S., Qi D., Li N., Guo P., Liu Z. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal. Fitoterapia. 2018;129:85\u201393. doi: 10.1016/j.fitote.2018.06.018.", "ArticleIdList": ["10.1016/j.fitote.2018.06.018", "29936192"]}, {"Citation": "Zhang J., Lv H., Jiang K., Gao Y. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int. J. Pharm. 2011;420:180\u2013188. doi: 10.1016/j.ijpharm.2011.08.023.", "ArticleIdList": ["10.1016/j.ijpharm.2011.08.023", "21878378"]}, {"Citation": "Liu W., Tian R., Hu W., Jia Y., Jiang H., Zhang J., Zhang L. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia. 2012;83:1532\u20131539. doi: 10.1016/j.fitote.2012.08.021.", "ArticleIdList": ["10.1016/j.fitote.2012.08.021", "22982454"]}, {"Citation": "Liu J., Qiu L., Gao J., Jin Y. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypro-pyl-beta-cyclodextrin. Int. J. Pharm. 2006;7:137\u2013143. doi: 10.1016/j.ijpharm.2006.01.011.", "ArticleIdList": ["10.1016/j.ijpharm.2006.01.011", "16459034"]}, {"Citation": "Liang J., Wu W., Liu Q., Chen S. Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo. Drug Deliv. 2013;20:319\u2013323. doi: 10.3109/10717544.2013.834420.", "ArticleIdList": ["10.3109/10717544.2013.834420", "24028326"]}, {"Citation": "Huang Y., Zhang B., Gao Y., Zhang J., Shi L. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. J. Pharm. Sci. 2014;103:2330\u20132337. doi: 10.1002/jps.24048.", "ArticleIdList": ["10.1002/jps.24048", "24903146"]}, {"Citation": "Wang S.X., Wen X., Bell C., Appiah S. Liposome-delivered baicalein induction of myeloid leukemia K562 cell death via reactive oxygen species generation. Mol. Med. Rep. 2018;17:4524\u20134530. doi: 10.3892/mmr.2018.8396.", "ArticleIdList": ["10.3892/mmr.2018.8396", "PMC5802230", "29328378"]}, {"Citation": "Li K., Zhang H., Gao L., Zhai Y., Shi M., Li J., Xiu C., Cao J., Cheng S., Jiang L., et al. Preparation and Characterization of Baicalein-Loaded Nanoliposomes for Antitumor Therapy. J. Nanomater. 2016;2016:2861915. doi: 10.1155/2016/2861915.", "ArticleIdList": ["10.1155/2016/2861915"]}, {"Citation": "Chen C.-H., Huang T.-S., Wong C.-H., Hong C.-L., Tsai Y.-H., Liang C.-C., Lu F.-J., Chang W.-H. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem. Toxicol. 2009;47:638\u2013644. doi: 10.1016/j.fct.2008.12.024.", "ArticleIdList": ["10.1016/j.fct.2008.12.024", "19150384"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "26"}, {"Year": "2022", "Month": "11", "Day": "11"}, {"Year": "2022", "Month": "11", "Day": "15"}, {"Year": "2022", "Month": "11", "Day": "26", "Hour": "1", "Minute": "28"}, {"Year": "2022", "Month": "11", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["36432119", "PMC9692503", "10.3390/molecules27228023", "molecules27228023"]}}], "PubmedBookArticle": []}